Attention-deficit hyperactivity disorder: Should we believe the mass media or peer-reviewed literature?

Psychiatric Bulletin

Volumn 29, Issue 8, 2005, Pages 288-291

  Coghill, Dave ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COGNITION; DIFFERENTIAL DIAGNOSIS; DRUG INDUSTRY; HUMAN; MASS MEDIUM; META ANALYSIS; PEER REVIEW; RELIABILITY; REVIEW; SIDE EFFECT; SUSTAINED RELEASE PREPARATION; SYSTEMATIC REVIEW; UNITED KINGDOM; VALIDATION PROCESS;

EID: 23844535370     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.29.8.288     Document Type: Review

References (38)

1. ABIKOFF, H., HECHTMAN, L., KLEIN, R. G., et al (2004) Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 802-811.
2. AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (1997) Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 85S-121S.
3. AMERICAN ACADEMY OF PEDIATRICS (2001) Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics, 108, 1033-1044.
4. AMERICAN PSYCHIATRIC ASSOCIATION (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
5. BARKLEY, R. A. (1998) A theory of ADHD: inhibition, executive functions, self-control, and time. In Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (ed. R. A. Barkley), pp. 225-260. New York: Guilford Press.
6. BARKLEY, R. A., FISCHER, M., EDELBROCK, C., et al (1991) The adolescent outcome of hyperactive children diagnosed by research criteria-III. Mother-child interactions family conflicts and maternal psychopathology. Journal of Child Psychology and Psychiatry, 32, 233-255.
7. BARKLEY, R. A., COOK, E. H., DIAMOND, A., et al (2002) International consensus statement on ADHD - January 2002. Clinical Child and Family Psychology Review, 5, 89-111.
8. BARKLEY, R. A., FISCHER, M., SMALLISH, L., et al (2004) Young adult follow-up of hyperactive children: antisocial activities and drug use. Journal of Child Psychology and Psychiatry, 45, 195-211.
9. CARLSON, G. A. (1998) Mania and ADHD: comorbidity or confusion. Journal of Affective Disorders, 51, 177-187.
10. CASTELLANOS, F. X. & TANNOCK, R. (2002) Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nature Reviews Neuroscience, 3, 517-628.
11. COGHILL, D., NIGG, J., ROTHENBERGER, A., et al (2005) Whither causal models in the neuroscience of ADHD? Developmental Science, 8, 105-114.
12. FARAONE, S.V. & DOYLE, A. E. (2000) Genetic influence on attention deficit hyperactivity disorder. Current Psychiatry Reports, 2, 143-146.
13. FARAONE, S.V., BIEDERMAN, J. & MILBERGER, S. (1995) How reliable are maternal reports of their children's psychopathology? One-year recall of psychiatric diagnoses of ADHD children. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1001-1008.
14. FISCHER, M., BARKLEY, R. A., EDELBROCK, C. S., et al (1990) The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status. Journal of Consulting and Clinical Psychology, 58, 580-588.
15. GOTTESMAN, I. I. & GOULD, T. D. (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160, 636-645.
16. HUSS, M. & LEHMKUHL, U. (2002) Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies. Journal of Attention Disorders, 6, S65-S71.
17. JADAD, A. R., BOOKER, L., GAULD, M., et al (1999) The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses. Canadian Journal of Psychiatry, 44, 1025-1035.
18. KREPPNER, J. M., O'CONNOR, T. G. & RUTTER, M. (2001) Can inattention/overactivity be an institutional deprivation syndrome? Journal of Abnormal Child Psychology, 29, 513-528.
19. KUPFER, D. J., BALTIMORE, R. S., BERRY, D. A., et al (2000) National Institutes of Health Consensus Development Conference Statement: Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). Journal of the American Academy of Child and Adolescent Psychiatry, 39, 182-193.
20. LAHEY, B. B., APPLEGATE, B., McBURNETT, K., et al (1994) DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. American Journal of Psychiatry, 151, 1673-1685.
21. MILBERGER, S., BIEDERMAN, J., FARAONE, S. V., et al (1997) Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. American Journal of Addiction, 6, 318-329.
22. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (2000) Guidance on the Use of Methylphenidate (Ritalin, Equasym) for Attention Deficit/Hyperactivity Disorder (ADHD) in Childhood. London: National Institute for Clinical Excellence.
23. NIGG, J.T., WILLCUTT, E. G., DOYLE, A. E., et al (2005) Causal heterogeneity in attention-deficit hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biological Psychiatry, 57, 1224-1230.
24. PHILP, A. V., WATSON, L. & MUIR, R. (2002) Mental Health in Scotland: Information Soucres and Selected Highlights, Edinburgh: NHS Scotland Information and Statistics Division.
25. RHODES, S. M., COGHILL, D. R. & MATTHEWS, K. (2004) Methyphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Psychopharmacology, 175, 319-330.
26. ROBINS, E. & GUZE, S. B. (1970) Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry, 126, 983-987.
27. SCHACHAR, R. & TANNOCK, R. (2002) Syndromes of hyperactivity and attention deficit. In Child and Adolescent Psychiatry (eds M. Rutter & E. Taylor), pp. 399-418. Oxford: Blackwell Science.
28. SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK (2001) Attention Deficit and Hyperkinetic Disorders in Children and Young People: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network.
29. SHAFFER, D., GOULD, M. S., BRASIE, J., et al (1983) A Children's Global Assessment Scale (CGAS). Archives of General Psychiatry, 40, 1228-1231.
30. SOLANTO, M. V., ARNSTEN, A. F. & CASTELLANOS, F. X. (2001) Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. New York: Oxford University Press.
31. SONUGA-BARKE, E. J. (2003) The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neuroscience and Biobehavioural Reviews, 27, 593-604.
32. SWANSON, J., GUPTA, S., GUINTA, D., et al (1999) Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clinical Pharmacology & Therapeutics, 66, 295-305.
33. TANNOCK, R., SCHACHAR, R. & LOGAN, C. (1995) Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. Journal of Abnormal Child Psychology, 23, 235-266.
34. TAYLOR, E., CHADWICK, O., HEPTINSTALL, E., et al (1996) Hyperactivity and conduct problems as risk factors for adolescent development. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1213-1226.
35. TAYLOR, E., DOPFNER, M., SERGEANT, J., et al (2005) Clinical guidelines for hyperkinetic disorder - first upgrade. European Child and Adolescent Psychiatry, 13 (suppl. 1), 17-30.
36. VOLKOW, N. D. & SWANSON, J. M. (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. American Journal of Psychiatry, 160, 1909-1918.
37. VOLKOW, N. D.,WANG, G. FOWLER, J. S., et al (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal of Neuroscience, 21, RC121.
38. WORLD HEALTH ORGANIZATION (1993) The ICO-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO.